Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve

Transfusion

Volumn 48, Issue 5, 2008, Pages 893-901

  Tijssen, Marloes R ^b   Woelders, Henri ^b   De Vries Van Rossen, Ada ^b   Van Der Schoot, C Ellen ^b   Voermans, Carlijn ^b   Lagerberg, Johan W M ^a  

^a SANQUIN RESEARCH   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE;

ARTICLE; CD34 SELECTION; CELL DEATH; CELL FUNCTION; CELL PROTECTION; CELL VIABILITY; COLONY FORMATION; CRYOPRESERVATION; FREEZE THAWING; FREEZING CURVE; HEMATOPOIESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MATHEMATICAL PARAMETERS; MEGAKARYOCYTE; NONLINEAR SYSTEM; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROCESS OPTIMIZATION; THEORETICAL MODEL;

ANTIGENS, CD34; BLOOD BANKS; BLOOD PRESERVATION; CELL SURVIVAL; CRYOPRESERVATION; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; MEGAKARYOCYTES; MODELS, BIOLOGICAL; MONOCYTES; NONLINEAR DYNAMICS;

EID: 42949160966     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2008.01650.x     Document Type: Article

References (25)

1. Dercksen MW, Rodenhuis S, Dirkson MK, Schaasberg WP, Baars JW, van der Wall E, Slaper-Cortenbach IC, von Pinedo HM, dem Borne AE, van der Schoot CE. Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation. J Clin Oncol 1995 13 : 1922 32.
2. Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, Hunstein W. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994 83 : 3787 94.
3. Hohaus S, Goldschmidt H, Ehrhardt R, Haas R. Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 1993 21 : 508 14.
4. de Boer F, Dräger AM, Pinedo HM, Kessler FL, Monnee-van Muijen M, Weijers G, Westra G, van der Wall E, Netelenbos T, Oberink JW, Huijgens PC, Schuurhuis GJ. Early apoptosis largely accounts for functional impairment of CD34+ cells in frozen-thawed stem cell grafts. J Hematother Stem Cell Res 2002 11 : 951 63.
5. Basser R. The impact of thrombopoietin on clinical practice. Curr Pharm Des 2002 8 : 369 77.
6. Stroncek DF, Fautsch SK, Lasky LC, Hurd DD, Ramsay NK, McCullough J. Adverse reactions in patients transfused with cryopreserved marrow. Transfusion 1991 31 : 521 6.
7. Lopez-Jimenez J, Cervero C, Munoz A, Hernandez-Madrid A, Fernandez PJ, Garcia LJ, Moro C, Maldonado M, Perez OJ, Otheo E. Cardiovascular toxicities related to the infusion of cryopreserved grafts: results of a controlled study. Bone Marrow Transplant 1994 13 : 789 93.
8. Zambelli A, Poggi G, Da PG, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della CG. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998 18 : 4705 8.
9. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990 75 : 781 6.
10. Takeyama K, Ohto H. PBSC mobilization. Transfus Apher Sci 2004 31 : 233 43.
11. Mazur P, Leibo SP, Chu EH. A two-factor hypothesis of freezing injury. Evidence from Chinese hamster tissue-culture cells. Exp Cell Res 1972 71 : 345 55.
12. Mazur P. Kinetics of water loss from cells at subzero temperatures and the likelihood of intracellular freezing. J Gen Physiol 1963 47 : 347 69.
13. Liu J, Christian JA, Critser JK. Canine RBC osmotic tolerance and membrane permeability. Cryobiology 2002 44 : 258 68.
14. Woods EJ, Liu J, Pollok K, Hartwell J, Smith FO, Williams DA, Yoder MC, Critser JK. A theoretically optimized method for cord blood stem cell cryopreservation. J Hematother Stem Cell Res 2003 12 : 341 50.
15. Woelders H, Chaveiro A. Theoretical prediction of "optimal" freezing programmes. Cryobiology 2004 49 : 258 71.
16. Woods EJ, Liu J, Derrow CW, Smith FO, Williams DA, Critser JK. Osmometric and permeability characteristics of human placental/umbilical cord blood CD34+ cells and their application to cryopreservation. J Hematother Stem Cell Res 2000 9 : 161 73.
17. Du Bois MJ, Schellekens PT, De Wit JJ, Eijsvoogel VP. In vitro reactivity of human lymphocytes after cryopreservation using a programmed cooling device. Scand J Immunol Suppl 1976 5 : 17 22.
18. McGann LE, Janowska-Wieczorek A, Turner AR, Hogg L, Muldrew KB, Turc JM. Water permeability of human hematopoietic stem cells. Cryobiology 1987 24 : 112 9.
19. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998 34 : 61 70.
20. Idziorek T, Estaquier J, De Bels F, Ameisen JC. YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J Immunol Methods 1995 185 : 249 58.
21. Glisic-Milosavljevic S, Waukau J, Jana S, Jailwala P, Rovensky J, Ghosh S. Comparison of apoptosis and mortality measurements in peripheral blood mononuclear cells (PBMCs) using multiple methods. Cell Prolif 2005 38 : 301 11.
22. Mazur P. The role of intracellular freezing in the death of cells cooled at supraoptimal rates. Cryobiology 1977 14 : 251 72.
23. Law P, Alsop P, Dooley DC, Meryman HT. Studies of cell separation: a comparison of the osmotic response of human lymphocytes and granulocyte-monocyte progenitor cells. Cryobiology 1983 20 : 644 51.
24. Abrahamsen JF, Bakken AM, Bruserud O. Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 2002 42 : 1573 80.
25. Abrahamsen JF, Rusten L, Bakken AM, Bruserud O. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Transfusion 2004 44 : 785 9.